Published on
Sep 24, 2026
Vitruvias Therapeutics thyroid tablet recall gets FDA’s highest-risk rating - here’s what to check and what patients ...
A thyroid medicine recall is drawing attention after the US Food and Drug Administration gave the affected product its most serious recall classification. The recall involves one lot of Thyroid Tablets, USP 30 mg, which is sold by Vitruvias Therapeutics …
Source:
The Economic Times
-
Center-right
